Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Galectin Therapeutics Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 59 | 1 | 61 | +3 |
| Shares | 6.94M | 1.03K | 7.11M | +171.4K (+2.5%) |
| Value | $11.3M | $1.68K | $8.04M | −$3.27M (−28.9%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Galectin Therapeutics Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 35,398 | $40.0K | 0.00% |
| AE Wealth Management LLC | 15,541 | $17.6K | 0.00% |
| Beacon Capital Management, LLC | 12,605 | $14.2K | 0.00% |
| CoreCap Advisors, LLC | 9,195 | $10.4K | 0.00% |
| UBS Group AG | 5,561 | $6.28K | 0.00% |
| Belpointe Asset Management LLC | 1,066 | $1.21K | 0.00% |
| Money Concepts Capital Corp | 1,000 | $1.13K | 0.00% |
| Global Wealth Strategies & Associates | 1,000 | $1.13K | 0.00% |
Sold out (5)
Institutions that held Galectin Therapeutics Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Summit Trail Advisors, LLC | 23,855 | $39.0K |
| Wealthspire Advisors, LLC | 17,355 | $28.0K |
| Two Sigma Securities, LLC | 13,384 | $22.0K |
| BNP Paribas Arbitrage, SA | 13 | $21 |
| Royal Bank of Canada | 296 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Galectin Therapeutics Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| American Portfolios Advisors | 1,031 | $1.68K |